Try our beta test site

TAXUS® Element™ Paclitaxel-Eluting Coronary Stent System European Post-Approval Surveillance Study (TE-Prove) (TE-Prove)

This study has been completed.
Sponsor:
Collaborator:
Pharmaceutical Research Associates
Information provided by (Responsible Party):
Boston Scientific Corporation
ClinicalTrials.gov Identifier:
NCT01242696
First received: November 16, 2010
Last updated: February 2, 2017
Last verified: February 2017